Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Revenue in the second quarter jumped 36% year over year to $11.3 billion, easily topping expectations of $9.92 billion, according to estimates compiled...
Shares of Disney fell Wednesday as concerns about attendance at its theme parks overshadowed streaming profits and better-than-expected headline results. However, the quarter checked the boxes that matter most to us, making the stock decline a buying opportunity. Revenue in the fiscal third quarter totaled $23.16 billion, topping the...
Linde on Friday reported another impressive quarter, as the industrial gas supplier continues to demonstrate its reliability and value in a diversified stock portfolio. Revenue in the second quarter totaled $8.27 billion, a bit shy of the $8.32 expected by analysts, according to estimates compiled by LSEG. On annual...
Shares of Nextracker dropped in extended trading Thursday as questions about the solar technology firm's backlog of projects overshadowed its better-than-expected quarterly results. Revenue in its fiscal 2025 first-quarter rose 50% year over year to $719.9 million, far ahead of the $617.5 million expected by analysts, according to LSEG....
DuPont on Wednesday reported another beat-and-raise quarter, continuing a recovery partly driven by growing demand for AI chips — and rewarding our patience with the stock. Net sales in the three months ended June 30 totaled $3.17 billion, topping the $3.05 billion estimate, according to LSEG. Sales rose 2.5%...
Advanced Micro Devices on Tuesday proved it is an emerging force in the AI chip race, as its data center business helped fuel better-than-expected quarterly results. Revenue in the three months ended June 29 advanced 9% year over year to $5.84 billion, topping estimates of $5.72 billion, according to...
Procter & Gamble on Tuesday reported a messy fiscal fourth quarter, putting shares of the Tide detergent and Pampers maker on pace for their worst day in two years. The stock is understandably down, but this is not a thesis-changing report. Revenue in three months ended June 30 totaled...
Foot Locker surged Thursday after its quarterly earnings report showed signs that CEO Mary Dillon's turnaround plan is starting to pay off. The sneaker retailer isn't out of the woods just yet, but we're removing the stock from our penalty box and upgrading its rating. Revenue declined 2.7% year...
Shares of Linde fell on Thursday after the industrial gas giant reported mixed first-quarter results and its guidance left some investors wanting more. The sellers graciously gave us the opportunity to add to our position in Linde for the first time in more than two years. Revenue in the...
Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue...